dwarf
Lv41
450 积分
2023-11-03 加入
-
A novel bispecific antibody as an immunotherapeutic agent in hepatocellular carcinoma
2小时前
已完结
-
A first‐in‐human, single and multiple dose study of lunsekimig, a novel anti‐TSLP/anti‐IL‐13 NANOBODY® compound, in healthy volunteers
1个月前
已完结
-
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
1个月前
已完结
-
Structure-Based Affinity Maturation of Antibody Based on Double-Point Mutations
2个月前
已完结
-
Developing an antibody targeting CεmX of mIgE for the treatment of IgE-mediated diseases (HYP4P.305)
2个月前
已关闭
-
A novel brick for bispecific antibody construction
2个月前
已完结
-
CD23 + IgG1 + memory B cells are poised to switch to pathogenic IgE production in food allergy
2个月前
已完结
-
A Randomized, Single‐Dose, Parallel‐Controlled Phase I Clinical Comparison of an Omalizumab Biosimilar Candidate with Reference Omalizumab in Healthy Chinese Male Volunteers
5个月前
已完结
-
Safety, tolerability, pharmacokinetics and efficacy of HB0017, a humanized monoclonal antibody targeting IL-17A, in healthy subjects and patients with moderate to severe plaque psoriasis (PsO)
6个月前
已完结
-
Fusion peptide–directed antibodies: Humoral armor against HIV-1 infection
7个月前
已完结